Why US
Nuclear Shares Are Moving Up Again and Why They Are Pointing to New
Highs
Atlanta, GA -- April
15th,
2019 -- InvestorsHub
NewsWire -- US
Nuclear Corp. (USOTC:UCLE),
Emerging MicroCaps (EmergingMicroCaps.com)
-
Last year, US
Nuclear and MIFTEC formed an exclusive partnership and announced a
revolutionary and patented new way to make billions of dollars of
radioisotopes to supply a $10 Billion radioisotope industry that is
suffering from severe shortages and high costs.
-
Since then,
US Nuclear's
partner
MIFTEC, made history by achieving
1010
neutron flux from fusion power decisively
proving at UNR TeraWatt
Facility that
their radical new fusion technology works exactly as predicted and
can make billions of dollars of high-quality radioisotopes
for
half the current cost.
-
MIFTEC hired a
leading nuclear fusion design engineer from a National Lab and has
already completed design plans for the first commercial 10 Mega
Amperes LTD-X (linear transformer driver) Staged Z-Pinch Fusion
Generator that can be built in between 1 and 2 years, and US
Nuclear is now looking for locations to build MIFTEC's Fusion
Generators.
-
US
Nuclear and MIFTEC are the only companies in the world that
are able
to use MIFTEC's
breakthrough fusion power to make abundant high-quality
radioisotopes at half the cost. The closest competitor has only
been able to generate 1/100,000th
the power that
MIFTEC has already demonstrated.
Medical
radioisotopes are in big demand because they are the best-known
tools for diagnosing cancer and heart disease and for treating
about half of all cancers. Currently,
the vast majority
of radioisotopes are made in
only 5 large nuclear fission reactors that are very costly,
hazardous, subject to unexpected shutdowns, produce dangerous
long-term nuclear waste, and are all outside of the United
States. Worldwide
shortages are already impacting the quality of healthcare globally
and
experts warn about the likelihood
of further deterioration until a major new source for supply comes
on line. Last year, the Chalk River fission reactor in Canada that
was one of the largest suppliers of radioisotopes, shut down
permanently and is now being demolished.
Why US
Nuclear Shares are Running Again
Last year, when the company
announced that their partner, MIFTEC Labs discovered and patented a
revolutionary new way to make abundant high-quality radioisotopes
US Nuclear (OTC:
UCLE)
shares ran from $.40 to $5.00. Since then, investors have been
waiting for more news as UCLE shares quietly drifted back to where
they started. Recently, however, shares began moving back up again
to around $1.30 providing investors with a second chance to get in
at bargain share prices.
Recently, Emerging
MicroCaps
interviewed Jerry Simmons, CEO of MIFTEC
Labs and Bob Goldstein, CEO of US Nuclear to learn more details
about their progress and where they stand today. The interview
strongly suggests the reason why US Nuclear shares are moving up
again and why they appear destined to break the old high of $5.00.
Perhaps this run will go higher because their milestones
achievements have removed the biggest barriers to successfully
becoming a major player in this unfilled, high-need,
multi-billion-dollar market for essential medical
radioisotopes.
When asked what the biggest
milestone achievements have been since they first announced their
breakthrough technology last year, Jerry Simmons said,
"In the second half of last year we did what nobody else has ever
been able to do. Not even the big government projects. We made
history by generating Neutron Flux in excess of 1010
from fusion power using an isotope of hydrogen from seawater
instead of radioactive enriched uranium. This proves beyond any
doubt that our machine can make the isotopes used in nuclear
medicine (i.e. Mo-99, Tc-99m, cobalt 60, iodine, etc.). It is only
a matter now of simply scaling the power or electric current flow
of our machine up so we can achieve the greater Neutron Flux
of 1012+.
Dr. Hafiz Rahman, President and Chief Scientist and his staff at
MIFTEC Labs and the University of Nevada, Reno National Terawatt
Facility, tells us that our scientific experimental predictions and
the device will work as designed."
The pursuit of
fusion power has been elusive, and many have heard it for so long,
that the common
perception is that fusion power is still a long way off. The truth
is that it is here now and MIFTEC and their sister company
Magneto-Internal Fusion Technologies, Inc. (MIFTI) have
successfully achieved the greatest power ever from fusion which is
the same nuclear energy process happening in our sun and the stars.
The closest competitor known to MIFTEC claims they have achieved a
Neutron Flux of 105
from fusion
power. To illustrate how far ahead of the pack MIFTEC is, consider
that they have already achieved 1010
that is
100,000 times more powerful than the closest competitor.
Dr. Hafiz
Rahman says,
"To give you an idea of how advanced we are, when we achieve
1015,
it will be 10,000,000,000 (ten billion) times more powerful than
105.
That is more than enough power to create all the Neutron Flux we
need to supply low cost radioisotopes and power for production of
electricity with our compact, low cost machines."
Simmons
continuing,
"The machine we used at University of Nevada, Reno National
Terawatt Facility was a 1 MA (1 Mega Amp) machine which limited the
Neutron Flux we could generate to 1010.
Last year, we hired a top nuclear design engineer and he has
already completed the design for our new 10 MA (10 Mega Amps) LTD-X
Staged Z-Pinch Fusion Generator that is designed to generate
1015
Neutron
Flux that is extremely powerful and matches or exceeds the high
power of the fission reactors being used today for radioisotope
production. Our new generators are small and will fit into a
building close to where the radioisotopes will be used. Our
generators will be only a tiny fraction of the cost of the huge
nuclear fission reactors and linear accelerators, and there will be
no long-term hazardous radioactive waste to contend with that is
dangerous and extremely expensive. Nuclear fission reactors can
cost anywhere from several hundred million dollars to several
billion dollars and we estimate that our machine will sell for
around 3 to 5 million dollars. Our Staged Z-Pinch LTD-X Fusion
Generator will be small and compact and will require very few
people to operate. The bottom line is that we will be able to
deliver enormous amounts of high-quality radioisotopes for about
half today's cost."
About Bob Goldstein and Jerry Simmons
Bob Goldstein,
the CEO of US Nuclear, graduated from MIT with a degree in Physics
and has a degree in Engineering from Stanford. He has authored more than 40
white papers and presentations on radiation measurement and his
work has been met and approved by US Federal standards set by the EPA,
FDA, and NRC. He also works closely with
Los Alamos, Sandia and Jefferson National Labs.
His family's first experiences
in
nuclear physics
go back to the 1940's when his
father was involved in the historic Manhattan Project that
developed the atomic bomb.
Mr. Goldstein
founded US Nuclear and is known for delivering the most sensitive,
accurate and reliable instruments in the world. The quality of
their work is confirmed by a list of loyal and repeat customers
such as NASA, the EPA, Department of Energy, U.S. Air Force, U.S.
Army, U.S. Navy, MIT, Pacific Gas & Electric, General Electric,
Lawrence Livermore, Oakridge National Lab and many more.
Jerry Simmons
is the only person in the world who has founded two fusion energy
companies. In 1998, Mr. Simmons co-founded Tri-Alpha Energy that is
a now a multi-billion-dollar company with big early investors such
as Paul Allen's Vulcan Investments and Art Samburg's
hedge fund.
The company is now called TAE Technologies. Jerry also co-founded
Magneto-Internal Fusion Technologies, Inc. (MIFTI) and MIFTEC
Laboratories, Inc. MIFTI has been funded by the DOE/ARPA-E and
private investors. Mr. Simmons is very experienced and well
connected with government officials that are interested in nuclear
fusion based power and radioisotopes that are produced from fusion
power sources. Mr. Simmons has negotiated a work package between
MIFTEC Laboratories and Oak Ridge National Laboratory.
About US Nuclear
US Nuclear has
enjoyed a long-standing financial history of stable sales and
profitability, but in 2017 demand for US Nuclear's
products began
increasing and has continued at a high growth rate since. We saw a
sales increase of 50% in 2017 and 2018 numbers are due out soon and
are expected to show continued strong growth. Several new large
opportunities are blossoming in the underserved radioisotope
market, and the environmental monitoring market that is
forecast to hit $20
billion by 2021. For example, China is converting
all of
their
coal-fired power plants that are responsible for dangerous polluted
air and water, to about 200 fission nuclear reactors that all
require the best radiation monitoring equipment in order to insure
safety. The Chinese nuclear agency claims that each individual
nuclear power plant requires about $8,000,000 in the highest
quality and most reliable radiation monitoring devices and has
already met with Mr. Goldstein twice last year with the intention
of purchasing large orders of US Nuclear monitoring equipment. With
World Nuclear Power Organization's
forecast for a growing
number of nuclear power plants to produce electricity (none planned
to produce radioisotopes), the demand for radiation monitoring
devices also grows.
Other
large opportunities for US Nuclear are their unique products
recently offered for radon mitigation in homes and offices and the
use of drones to mount their sophisticated monitoring
devices.
Radon is commonly found in many homes and is one of the leading
known causes of lung cancer. Goldman Sachs sees the
drone market growing
to a very large size by 2020. Drones are the perfect vehicle for
carrying US Nuclear environmental monitoring devices for public
safety and for national security threats of terrorism that could
impact our air or water.
In
conclusion, US Nuclear is enjoying strong growth from its core
business, and on top of that, is well positioned to become a major
supplier in a multi-billion-dollar healthcare market of
radioisotopes.
Goldstein
says,
"Given the failing state of essential medical isotope production
facilities, this
first-ever achievement to meet and exceed the 1010
milestone
in fusion neutron production could not come at a better time.
Additionally, the projected cost savings of up to 50% over the
current imported resources; the idea of on-site production; the low
cost and shorter time to build the generators, and the
environmental benefit of a non-proliferating process that precludes
the hazards of fission-based methods; should make for important
upgrades ahead in the vital medical isotope supply chain."
US Nuclear reports only 17
million shares outstanding translating to a very small market cap
of about $20 million. Of the 17 million shares outstanding,
management owns about ten million shares. The float is small and
based on a
number of metrics including sales, the
share price is substantially undervalued. Any investor looking at
US Nuclear should run the numbers for themselves and calculate what
the shares could be valued at if their sales mushroomed to the
large numbers that just the radioisotope business can bring. The
big question is, "How much of a $10 Billion-dollar market (that is
expected to be $17 Billion in 2020), can US Nuclear and MIFTEC own
if they can deliver valuable, high demand radioisotopes at
half-price?
And if US Nuclear generates billion-dollar
sales with only
17 million shares outstanding, how high will the price go? With the
best science, the best solution, and the capability to deliver high
quality radioisotopes at half the current cost, it seems likely
that UCLE and MIFTEC can capture at least 50% of the $7 billion
shortage and a similar amount of the $10 billion supply. Running
the numbers suggests very lofty prices.
US Nuclear shares appear to
be a bargain at anything under $5.00 and poised for record
highs in
the not too distant future.
Contact:
Emerging
MicroCaps
Atlanta,
GA
EmergingMicroCaps.com
US Nuclear
Corp. (UCLE)